2025’s Nursing Home Staffing Whiplash: What Bedside Nurses Need to Know Top Nurse CE | October 14, 2025 By Linnea […]
2025’s Nursing Home Staffing Whiplash: What Bedside Nurses Need to Know Read More »
Nurses on the Frontlines of Suicide Prevention: Saving Lives, Supporting Each Other Suicide is a growing public health crisis—and nurses
Nurses on the Frontlines of Suicide Prevention: Saving Lives, Supporting Each Other Read More »
Healing the Gut Microbiome: A New Frontier in Type 2 Diabetes Care In the ever-evolving landscape of chronic disease management,
Healing the Gut Microbiome: A New Frontier in Type 2 Diabetes Care Read More »
From Burnout to Balance: Self-Care Tips for Busy Nurses Nursing is one of the most rewarding careers in the world—but
From Burnout to Balance: Self-Care Tips for Busy Nurses Read More »
Public Health Nursing at the Forefront: Addressing Community Needs in a Changing World Top Nurse CE | June 14, 2025
Public Health Nursing at the Forefront: Addressing Community Needs in a Changing World Read More »
Public Health Nursing: Leading Change, Saving Lives, Empowering Communities Public health nurses are the unsung heroes of the healthcare system.
The Power of the Nurse’s Voice: Advocacy at the Bedside and Beyond Read More »
In today’s fast-paced healthcare environment, staying up to date isn’t just helpful—it’s essential. The best nurses know that continuing education
Why the Best Nurses Never Stop Learning: A 2025 Guide to CE That Actually Matters Read More »
As healthcare continues to evolve, nurses are adapting by embracing emerging specialties that address growing concerns and integrate new technologies.
Nurses Embrace Emerging Specialties and Technologies Read More »
Thousands of Californians relying on the state’s In-Home Supportive Services (IHSS) program face uncertainty due to proposed federal Medicaid cuts
California’s In-Home Care Services Threatened by Proposed Medicaid Cuts Read More »
The U.S. Food and Drug Administration has approved retifanlimab-dlwr (Zynyz) for the treatment of locally recurrent or metastatic squamous cell
FDA Approves Retifanlimab (Zynyz) for Advanced Anal Cancer Read More »
